Advertisement

Topics

Mylan CEO Bresch grilled by Congress over EpiPen

05:09 EDT 22 Sep 2016 | BioPharmaDive

Bresch's showdown with the House Oversight Committee bore some similarities to hearings earlier this year criticizing CEOs from Valeant and Turing over high drug prices. 

Original Article: Mylan CEO Bresch grilled by Congress over EpiPen

NEXT ARTICLE

More From BioPortfolio on "Mylan CEO Bresch grilled by Congress over EpiPen"

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...